Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Strontium-Functionalized Biomaterials for Bone Regeneration: Mechanisms, Biological Functions, and Clinical Translational Progress

Ning F., Wang X., Pan P., Liu W., Yan G., Wang X.

Narrative Review on Immune Modulation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42338898
PMCID
PMC13285936
DOI
10.2147/ijn.s611430

Abstract (original English)

Strontium (Sr), a trace element with osteogenic, anti-resorptive, immunomodulatory, angiogenic, and antibacterial activities, has become an important functional component in biomaterials for bone regeneration. This review systematically summarizes Sr-functionalized biomaterials, with emphasis on Sr 2 ⁺-mediated molecular mechanisms, concentration-dependent bioactivity, local delivery strategies, fabrication-dependent ion-release behavior, antimicrobial and antioxidant functions, and clinical translational potential. Particular attention is given to the physicochemical regulation of Sr incorporation, therapeutic-ion synergy, fabrication-related release characteristics, and key challenges affecting translational application. In addition, we discuss how Sr cooperates with other therapeutic ions, including Mg, Zn, Cu, Se, and Ga, to coordinate osteogenesis, angiogenesis, immunomodulation, and infection control within the bone-regeneration microenvironment. Current limitations include the lack of unified optimal Sr dosing across different material platforms, insufficient long-term release and biosafety data, limited large-animal and clinical evidence, and an incomplete understanding of Sr-associated antimicrobial mechanisms. Overall, this review provides mechanistic insights and practical guidance for the rational design of next-generation Sr-functionalized bone-repair biomaterials.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansStrontiumBiocompatible MaterialsBone RegenerationTranslational Research, Biomedical

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research